Article
Selective miRNA Expression Profile in Chronic Myeloid Leukemia K562 Cell-derived Exosomes
31 Dec 2013
Abstract excerpt
BACKGROUND: Chronic myeloid leukemia (CML) is a myeloproliferative disorder of hematopoietic stem cell scarrying the Philadelphia (Ph) chromosome and an oncogenic BCR-ABL1 fusion gene. The tyrosine kinase inhibitor (TKI) of BCR-ABL1 kinase is a treatment of choice for control of CML. OBJECTIVE: Recent studies have demonstrated that miRNAs within exosomes from cancer cells play crucial roles in initiation and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
